215 related articles for article (PubMed ID: 33920772)
1. Epstein-Barr Virus LMP1 Modulates the CD63 Interactome.
Cheerathodi M; Nkosi D; Cone AS; York SB; Meckes DG
Viruses; 2021 Apr; 13(4):. PubMed ID: 33920772
[TBL] [Abstract][Full Text] [Related]
2. Tetraspanin CD63 Bridges Autophagic and Endosomal Processes To Regulate Exosomal Secretion and Intracellular Signaling of Epstein-Barr Virus LMP1.
Hurwitz SN; Cheerathodi MR; Nkosi D; York SB; Meckes DG
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212935
[TBL] [Abstract][Full Text] [Related]
3. CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.
Hurwitz SN; Nkosi D; Conlon MM; York SB; Liu X; Tremblay DC; Meckes DG
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974566
[TBL] [Abstract][Full Text] [Related]
4. The interactome of EBV LMP1 evaluated by proximity-based BioID approach.
Rider MA; Cheerathodi MR; Hurwitz SN; Nkosi D; Howell LA; Tremblay DC; Liu X; Zhu F; Meckes DG
Virology; 2018 Mar; 516():55-70. PubMed ID: 29329079
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1.
Nkosi D; Howell LA; Cheerathodi MR; Hurwitz SN; Tremblay DC; Liu X; Meckes DG
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950415
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus LMP1 Promotes Syntenin-1- and Hrs-Induced Extracellular Vesicle Formation for Its Own Secretion To Increase Cell Proliferation and Migration.
Nkosi D; Sun L; Duke LC; Patel N; Surapaneni SK; Singh M; Meckes DG
mBio; 2020 Jun; 11(3):. PubMed ID: 32546618
[TBL] [Abstract][Full Text] [Related]
7. Ceramide-dependent trafficking of Epstein-Barr virus LMP1 to small extracellular vesicles.
York SB; Hurwitz SN; Liu X; Meckes DG
Virology; 2023 Apr; 581():128-138. PubMed ID: 36958217
[TBL] [Abstract][Full Text] [Related]
8. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation.
Verweij FJ; van Eijndhoven MA; Hopmans ES; Vendrig T; Wurdinger T; Cahir-McFarland E; Kieff E; Geerts D; van der Kant R; Neefjes J; Middeldorp JM; Pegtel DM
EMBO J; 2011 Jun; 30(11):2115-29. PubMed ID: 21527913
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus LMP1 manipulates the content and functions of extracellular vesicles to enhance metastatic potential of recipient cells.
Nkosi D; Sun L; Duke LC; Meckes DG
PLoS Pathog; 2020 Dec; 16(12):e1009023. PubMed ID: 33382850
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan-2 and synaptotagmin-like-4 in nasopharyngeal carcinoma cells.
Liao C; Zhou Q; Zhang Z; Wu X; Zhou Z; Li B; Peng J; Shen L; Li D; Luo X; Yang L
Cancer Sci; 2020 Mar; 111(3):857-868. PubMed ID: 31930596
[TBL] [Abstract][Full Text] [Related]
11. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
12. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.
Gewurz BE; Mar JC; Padi M; Zhao B; Shinners NP; Takasaki K; Bedoya E; Zou JY; Cahir-McFarland E; Quackenbush J; Kieff E
J Virol; 2011 Jul; 85(13):6764-73. PubMed ID: 21543491
[TBL] [Abstract][Full Text] [Related]
13. Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.
DeKroon RM; Gunawardena HP; Edwards R; Raab-Traub N
mBio; 2018 Jun; 9(3):. PubMed ID: 29921667
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
[TBL] [Abstract][Full Text] [Related]
15. Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.
Terrin L; Dal Col J; Rampazzo E; Zancai P; Pedrotti M; Ammirabile G; Bergamin S; Rizzo S; Dolcetti R; De Rossi A
J Virol; 2008 Oct; 82(20):10175-87. PubMed ID: 18684838
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
17. The Latent Membrane Protein 1 (LMP1).
Kieser A; Sterz KR
Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
[TBL] [Abstract][Full Text] [Related]
18. [Functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with limphoproliferative disorders].
Smirnova KV; Diduk SV; Gurtsevich VÉ
Biomed Khim; 2011; 57(1):114-26. PubMed ID: 21516783
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the rapamycin-inducible EBV LMP1 activation system.
Kim SY; Kim JE; Won J; Song YJ
J Microbiol; 2015 Oct; 53(10):732-8. PubMed ID: 26428925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]